Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19)

  • STATUS
    Recruiting
  • participants needed
    60
  • sponsor
    Hopital Foch
Send
Updated on 16 February 2024
See if I qualify
respiratory disorder
covid-19
SARS
volatile organic compounds
acute respiratory syndrome (sars)

Summary

The study of volatile organic compounds (VOCs) detected in exhaled air is an innovative research area for respiratory diseases. This analysis can be done by the technique of electronic nose, simpler and faster, which provides an idea of the general profile of the VOCs without identifying them. The VOCs in exhaled air in patients hospitalized for COVID-19 infection are analysed in this study, using electronic noses.

Details
Condition Covid 19
Age 18years - 100years
Treatment Volatile Organic Compounds analysis
Clinical Study IdentifierNCT04379154
SponsorHopital Foch
Last Modified on16 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Patients infected by SARS-CoV-2 whose medical condition warrants hospitalisation (out of intensive care) for oxygen therapy less or equal to 4 l/min
Patients must be 18 years of age or older
Fluent in the French language
Have signed a consent form
Being affiliated with healthcare insurance

Exclusion Criteria

Pregnant woman
Patient deprived of liberty by judicial or administrative decision
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

respiratory disorder
covid-19
SARS
volatile organic compounds
acute respiratory syndrome (sars)

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.